Trial Profile
Retrospective Data Collection and Analysis of the Therapeutic Effect of Eribulin for Advanced Breast Cancer Patients.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Apr 2019
Price :
$35
*
At a glance
- Drugs Eribulin (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 14 Aug 2017 New trial record